drug pricing
16 stories related to this topic, newest first.
Washington ExaminerTrump Administration Considers Most Favored Nation Drug Pricing Policy
The proposal would link U.S. prescription drug prices to the lowest prices paid by foreign governments. A patient advocate argues the approach could reduce funding for pharmaceutical research and limit patient access to new medicines.
prnewswire.comVirginia Governor Vetoes Bill Creating Drug Cost Advisory Panel
Virginia Gov. Abigail Spanberger vetoed legislation that would have created an advisory panel to lower prescription drug costs. The panel would have used Medicare benchmarks and set upper payment limits.
New York PostTrumpRx Adds Over 600 Generic Drugs to Online Platform
President Trump announced the expansion of the federal drug-pricing site TrumpRx to include more than 600 generic medications. The platform now directs users to discounted options from several manufacturers and delivery services.
foxbusiness.comMaryland Board Sets $274 Monthly Cap on Ozempic for State Purchases
The Maryland Prescription Drug Affordability Board voted to cap the price of Ozempic at $274 per 30-day supply for state and local government purchases starting January 2027. The limit is expected to save $5.8 million annually and follows a similar action taken by the board in re…
StatU.S. Officials Urge Germany to Increase Payments for Medicines
Trump administration officials told the German ambassador to the United States that Germany should pay more for medicines. The message was delivered at a recent meeting, according to a person familiar with the encounter. STAT reported the development on May 15, 2026.
StatU.S. Officials Press Germany to Raise Drug Prices in Bid to Lower American Costs
U.S. officials told the German ambassador that Germany should pay more for pharmaceuticals as part of a broader effort to reduce prices paid in the United States. The meeting involved the U.S. Trade Representative and a senior health department adviser. Separately, some U.S. biot…
StatU.S. and Germany Discuss Fairer Global Split of Pharmaceutical Costs in Washington Meeting
U.S. Trade Representative Jamieson Greer and chief health department adviser Chris Klomp told German Ambassador Jens Hanefeld over breakfast that Germany should pay more for prescription drugs. The discussion included possible tariffs under Section 301 as part of a broader Trump…
StatMedicare Spending on Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections
Uptake of the recently approved intravenous medications has been far lower than anticipated, prompting the Centers for Medicare and Medicaid Services to project no significant spending in 2026 or 2027. The muted adoption marks a sharp reversal from projections made two years ago.
prnewswire.comCapricor Therapeutics Sues Nippon Shinyaku and NS Pharma Over Pricing Dispute on Duchenne Muscular Dystrophy Therapy Deramiocel
Capricor Therapeutics filed suit in New Jersey state court on May 8, 2026, accusing Nippon Shinyaku and its U.S. subsidiary NS Pharma of failing to execute marketing plans for deramiocel and refusing to correct a pricing formula flaw discovered in March 2025.
StatTrump Administration Announces Projected Savings From Drug Pricing Agreements
The Trump administration is touting massive projected savings from still-secret drug pricing deals even as outside experts question how independently verifiable the figures are. STAT reported on the claims alongside fresh accusations of political interference at the FDA, which wi…
Mike Burdett from CROMER, UK / Wikimedia (CC BY-SA 2.0)Dozens of MPs Oppose Health Secretary's New NHS Drug Payment Powers
Dozens of MPs have expressed opposition to a health secretary's decision to gain authority over NHS drug pricing. The move involves overriding an institute's judgments on cost-effectiveness amid concerns about legality and potential benefits to pharmaceutical companies. Critics i…
marketwatch.comRegeneron Agrees to Lower Drug Prices and Offer Free Gene Therapy in U.S. Deal
Biotech company Regeneron has entered into an agreement with the U.S. government to reduce medication costs for American patients. The deal includes offering a new hearing-loss gene therapy at no charge to eligible individuals. This is part of broader efforts to align U.S. drug p…
Substrate placeholder — needs reviewChina's State Council Issues Guidelines on Innovative Drug Pricing
China's State Council has released new guidelines aimed at supporting innovative drug pricing through value-based methods while reducing generic drug prices via market competition. A Citigroup analyst described the guidelines as the most significant in a decade.
medpagetoday.comFDA to Review Compounding Pharmacies’ Peptide Manufacturing; Alzheimer’s Drug Benefits Under Review
The FDA will hold an advisory panel meeting to consider allowing compounding pharmacies to produce certain peptides. A recent review of Alzheimer’s drugs found limited clinical benefits, though some experts noted differences among the drugs studied. Additionally, a report indicat…
Substrate placeholder — needs reviewMaryland Board Establishes $204 Monthly Cap on Jardiance for Public Purchases by 2027
The Maryland Prescription Drug Affordability Board has established an upper payment limit for Jardiance, a type 2 diabetes medicine, capping its price at $204 for a 30-day supply by January 2027. The board will oversee a process to lower costs for state and local governments. The…
The Boston GlobeReader Responses to GLP-1 Weight Loss Drugs and Insurance Coverage Changes
Readers of The Boston Globe have shared varied opinions on GLP-1 medications for obesity treatment following a February 22 article. Some highlight the drugs' benefits for health conditions beyond weight loss, while others question obesity as a disease and oppose insurance subsidi…